ASH News Daily 2017 - Issue 2 - A-18
ASH NEWS DAILY
Page A-18
Sunday, December 10, 2017
®
ASH Live: Today's Remote Session Viewing Schedule
ASH Central: Hall B1
7:30 - 9:00 a.m.
9:30 - 11:00 a.m.
11:15 a.m. -
12:15 p.m.
904. Outcomes
Research-Malignant
Conditions: Quality Of
Life and Outcomes in
Myelodysplastic Syndromes and Leukemias
Special Scientific Symposium on Targeted
Therapy: What Is the
Best Target?
Featured Topic:
Hemophilia Revolution
632. Chronic Myeloid
Leukemia: Therapy:
Treatment Discontinuation, Dose Reduction, and Prognostic
Indicators
627. Aggressive
Lymphoma (Diffuse
Large B Cell and Other
Aggressive B Cell
Non- Hodgkin
Lymphomas)
Quality
Conversations on
Social Media:
Achieving Credibility and Efficiency
Together
621. Lymphoma-
Genetic/Epigene tic
Biology: Molecular approaches to describe,
monitor, and target
lymphoma
731. Clinical
Autologous
Transplantation:
Results: Novel
Conditioning & Maintenance Approaches
627. Aggressive
Lymphoma (Diffuse
Large B Cell and Other
Aggressive B Cell NonHodgkin Lymphomas)
Channel 4
Individualizing Therapy
in Chronic Lymphocytic Leukemia
Clonal Evolution in
Myeloid Malignancies
637. Myelodysplastic
Syndromes-Clinical
Studies: Inflammation,
Immunity, and Iron
Channel 5
Hodgkin Lymphoma:
New Insights and New
Approaches
The Expanding Role of
Immunotherapy
in Non-Hodgkin
Lymphoma
623. Mantle Cell,
Follicular, and Other
Indolent B Cell
Lymphoma
Channel 6
Dilemmas in Pediatric
Hematologic
Malignancy
Novel Epigenetic
Modifications in Cancer and Development
642. CLL: Therapy,
excluding Transplantation: Targeting MRD
Negative CLL Through
Combinations of Novel
Agents and Antibody
Channel 7
617. Acute Myeloid
Leukemia: Biology,
Cytogenetics, and
Molecular Markers in
Diagnosis and Prognosis
New Innovations in
Platelet Regulation of
Tumor Growth and
Metastasis
623. Mantle Cell,
Follicular, and Other
Indolent B Cell
Lymphoma
Channel 8
634. Myeloproliferative Syndromes:
Clinical: Phase III and
Long-Term Outcome
Studies in MPNs
635. Myeloproliferative Syndromes: Basic
Science: Identification of novel targets
for the treatment of
myeloproliferative
neoplasms
653. Myeloma: Therapy, excluding Transplantation: Upfront
Therapy for Multiple
Myeloma: Induction
and Maintenance
723. Clinical Allogeneic and Autologous
Transplantation: Late
Complications and
Approaches to Disease
Recurrence
618. Acute Lymphoblastic Leukemia:
Biology, Cytogenetics,
and Molecular Markers in Diagnosis and
Prognosis: Biology,
Signaling Mechanisms,
and Response in ALL
Channel 10
New Approaches to
Understanding Microbial Immune System
Interactions
Next-Generation
Sequencing in Routine
Diagnostics: Are We
There Yet?
Channel 11
Hematopoietic Stem
Cell Generation:
Reprogramming and
Expansion
Targeting T
Cell Exhaustion
Therapeutic Apheresis
as an Immunomodulatory Tool
Indolent Lymphoma:
How Understanding
Disease Biology Is
Influencing Clinical
Decision-Making
Channel 1
Channel 2
Channel 3
Channel 9
Channel 12
Noon - 1:30 p.m.
12:30 - 1:30 p.m. 1:30 - 2:00 p.m.
Announcement of
Awards: ASH Mentor
Awards, ASH Award
for Leadership in Promoting Diversity, ASH
Outstanding Service
Award, ASH Public Service Award, and Wallace H. Coulter Award
for Lifetime Achievement in Hematology
ASH-EHA Joint
Symposium
Table of Contents for the Digital Edition of ASH News Daily 2017 - Issue 2
ASH News Daily 2017 - Issue 2 - A-1
ASH News Daily 2017 - Issue 2 - A-2
ASH News Daily 2017 - Issue 2 - A-3
ASH News Daily 2017 - Issue 2 - A-4
ASH News Daily 2017 - Issue 2 - A-5
ASH News Daily 2017 - Issue 2 - A-6
ASH News Daily 2017 - Issue 2 - A-7
ASH News Daily 2017 - Issue 2 - A-8
ASH News Daily 2017 - Issue 2 - A-9
ASH News Daily 2017 - Issue 2 - A-10
ASH News Daily 2017 - Issue 2 - A-11
ASH News Daily 2017 - Issue 2 - A-12
ASH News Daily 2017 - Issue 2 - A-13
ASH News Daily 2017 - Issue 2 - A-14
ASH News Daily 2017 - Issue 2 - A-15
ASH News Daily 2017 - Issue 2 - A-16
ASH News Daily 2017 - Issue 2 - A-17
ASH News Daily 2017 - Issue 2 - A-18
ASH News Daily 2017 - Issue 2 - A-19
ASH News Daily 2017 - Issue 2 - A-20
ASH News Daily 2017 - Issue 2 - A-21
ASH News Daily 2017 - Issue 2 - A-22
ASH News Daily 2017 - Issue 2 - A-23
ASH News Daily 2017 - Issue 2 - A-24
ASH News Daily 2017 - Issue 2 - A-25
ASH News Daily 2017 - Issue 2 - A-26
ASH News Daily 2017 - Issue 2 - A-27
ASH News Daily 2017 - Issue 2 - A-28
ASH News Daily 2017 - Issue 2 - B-1
ASH News Daily 2017 - Issue 2 - B-2
ASH News Daily 2017 - Issue 2 - B-3
ASH News Daily 2017 - Issue 2 - B-4
ASH News Daily 2017 - Issue 2 - B-5
ASH News Daily 2017 - Issue 2 - B-6
ASH News Daily 2017 - Issue 2 - B-7
ASH News Daily 2017 - Issue 2 - B-8
ASH News Daily 2017 - Issue 2 - B-9
ASH News Daily 2017 - Issue 2 - B-10
ASH News Daily 2017 - Issue 2 - B-11
ASH News Daily 2017 - Issue 2 - B-12
ASH News Daily 2017 - Issue 2 - B-13
ASH News Daily 2017 - Issue 2 - B-14
ASH News Daily 2017 - Issue 2 - B-15
ASH News Daily 2017 - Issue 2 - B-16
ASH News Daily 2017 - Issue 2 - B-17
ASH News Daily 2017 - Issue 2 - B-18
ASH News Daily 2017 - Issue 2 - B-19
ASH News Daily 2017 - Issue 2 - B-20
ASH News Daily 2017 - Issue 2 - B-21
ASH News Daily 2017 - Issue 2 - B-22
ASH News Daily 2017 - Issue 2 - B-23
ASH News Daily 2017 - Issue 2 - B-24
ASH News Daily 2017 - Issue 2 - B-25
ASH News Daily 2017 - Issue 2 - B-26
ASH News Daily 2017 - Issue 2 - B-27
ASH News Daily 2017 - Issue 2 - B-28
ASH News Daily 2017 - Issue 2 - B-29
ASH News Daily 2017 - Issue 2 - B-30
ASH News Daily 2017 - Issue 2 - B-31
ASH News Daily 2017 - Issue 2 - B-32
ASH News Daily 2017 - Issue 2 - B-33
ASH News Daily 2017 - Issue 2 - B-34
ASH News Daily 2017 - Issue 2 - B-35
ASH News Daily 2017 - Issue 2 - B-36
ASH News Daily 2017 - Issue 2 - B-37
ASH News Daily 2017 - Issue 2 - B-38
ASH News Daily 2017 - Issue 2 - B-39
ASH News Daily 2017 - Issue 2 - B-40
ASH News Daily 2017 - Issue 2 - B-41
ASH News Daily 2017 - Issue 2 - B-42
ASH News Daily 2017 - Issue 2 - B-43
ASH News Daily 2017 - Issue 2 - B-44
ASH News Daily 2017 - Issue 2 - B-45
ASH News Daily 2017 - Issue 2 - B-46
ASH News Daily 2017 - Issue 2 - B-47
ASH News Daily 2017 - Issue 2 - B-48
ASH News Daily 2017 - Issue 2 - B-49
ASH News Daily 2017 - Issue 2 - B-50
ASH News Daily 2017 - Issue 2 - B-51
ASH News Daily 2017 - Issue 2 - B-52
ASH News Daily 2017 - Issue 2 - B-53
ASH News Daily 2017 - Issue 2 - B-54
ASH News Daily 2017 - Issue 2 - B-55
ASH News Daily 2017 - Issue 2 - B-56
ASH News Daily 2017 - Issue 2 - C-1
ASH News Daily 2017 - Issue 2 - C-2
ASH News Daily 2017 - Issue 2 - C-3
ASH News Daily 2017 - Issue 2 - C-4
ASH News Daily 2017 - Issue 2 - C-5
ASH News Daily 2017 - Issue 2 - C-6
ASH News Daily 2017 - Issue 2 - C-7
ASH News Daily 2017 - Issue 2 - C-8
ASH News Daily 2017 - Issue 2 - C-9
ASH News Daily 2017 - Issue 2 - C-10
ASH News Daily 2017 - Issue 2 - C-11
ASH News Daily 2017 - Issue 2 - C-12
ASH News Daily 2017 - Issue 2 - C-13
ASH News Daily 2017 - Issue 2 - C-14
ASH News Daily 2017 - Issue 2 - C-15
ASH News Daily 2017 - Issue 2 - C-16
ASH News Daily 2017 - Issue 2 - C-17
ASH News Daily 2017 - Issue 2 - C-18
ASH News Daily 2017 - Issue 2 - C-19
ASH News Daily 2017 - Issue 2 - C-20
ASH News Daily 2017 - Issue 2 - C-21
ASH News Daily 2017 - Issue 2 - C-22
ASH News Daily 2017 - Issue 2 - C-23
ASH News Daily 2017 - Issue 2 - C-24
ASH News Daily 2017 - Issue 2 - C-25
ASH News Daily 2017 - Issue 2 - C-26
ASH News Daily 2017 - Issue 2 - C-27
ASH News Daily 2017 - Issue 2 - C-28
ASH News Daily 2017 - Issue 2 - C-29
ASH News Daily 2017 - Issue 2 - C-30
ASH News Daily 2017 - Issue 2 - C-31
ASH News Daily 2017 - Issue 2 - C-32
https://www.nxtbookmedia.com